Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Clinical trial compares therapeutic potential of heparin and hirudin in coronary thrombosis

Nov. 21, 1996

Hirudin-based thrombin inhibitors reported by Canadian investigators

Nov. 19, 1996

CAPRIE study demonstrates clopidogrel more effective than aspirin

Nov. 15, 1996

Preclinical and clinical pharmacological profile of efegatran

Nov. 15, 1996

Ciba-Geigy describes trypsin/thrombin inhibitors

Nov. 15, 1996

FDA clears new heart attack drug

Nov. 8, 1996

Japanese researchers report potential fibrinolytic agent

Nov. 8, 1996

Novel PAI-1 inhibitor discovered by Xenova

Nov. 8, 1996

Nycomed suspends development of anticlotting agent

Nov. 8, 1996

Cor Therapeutics' fibrinogen receptor antagonist effective in unstable angina

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...